NASDAQ:AMDA - Amedica Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous Close$0.2260Today's Range$0.21 - $0.2452-Week Range$0.18 - $6.40Volume206,510 shsAverage Volume1.07 million shsMarket Capitalization$3.44 millionP/E Ratio-0.07Dividend YieldN/ABeta-1.24 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Amedica Corporation, a biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. The company offers silicon nitride implants to surgeons and hospitals for use in cervical and thoracolumbar spine surgery under the Valeo brand. It also provides a line of non-silicon nitride spinal fixation products to address spinal deformity and degenerative conditions. The company markets and sells its products directly; and through a network of independent sales distributors, as well original equipment manufacturer and private label partnerships. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah. Receive AMDA News and Ratings via Email Sign-up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AMDA Previous Symbol CUSIPN/A Webwww.amedica.com Phone801-839-3500Debt Debt-to-Equity RatioN/A Current Ratio1.11 Quick Ratio0.99Price-To-Earnings Trailing P/E Ratio-0.07 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$11.23 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.80 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)($3.13) Net Income$-9,320,000.00 Net Margins-139.62% Return on Equity-148.60% Return on Assets-67.83%Miscellaneous Employees33 Outstanding Shares11,870,000Market Cap$3.44 million OptionableNot Optionable Amedica (NASDAQ:AMDA) Frequently Asked Questions What is Amedica's stock symbol? Amedica trades on the NASDAQ under the ticker symbol "AMDA." When did Amedica's stock split? How did Amedica's stock split work? Amedica's stock reverse split before market open on Friday, November 10th 2017. The 1-12 reverse split was announced on Friday, November 10th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 9th 2017. An investor that had 100 shares of Amedica stock prior to the reverse split would have 8 shares after the split. How were Amedica's earnings last quarter? Amedica Co. (NASDAQ:AMDA) issued its quarterly earnings data on Tuesday, November, 21st. The medical equipment provider reported ($0.93) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.94) by $0.01. The medical equipment provider earned $2.96 million during the quarter. Amedica had a negative return on equity of 148.60% and a negative net margin of 139.62%. View Amedica's Earnings History. What is the consensus analysts' recommendation for Amedica? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amedica in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Amedica. Has Amedica been receiving favorable news coverage? News articles about AMDA stock have been trending positive this week, according to InfoTrie. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Amedica earned a news sentiment score of 2.3 on InfoTrie's scale. They also gave news stories about the medical equipment provider a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the stock's share price in the near future. Who are some of Amedica's key competitors? Some companies that are related to Amedica include Biostage (BSTG), Alliqua Biomedical (ALQA), Valeritas (VLRX), Presbia (LENS), Neurometrix (NURO), Avinger (AVGR), Atossa Genetics (ATOS), Viatar CTC Solutions (VRTT), United American Healthcare (UAHC), Cytori Therapeutics (CYTX), Encision (ECIA), Delcath Systems (DCTH), Regenicin (RGIN), Cytocore (MDIT) and Calmare Therapeutics (CTTC). Who are Amedica's key executives? Amedica's management team includes the folowing people: Dr. B. Sonny Bal, Chairman, CEO, Pres & Principal Financial Officer (Age 56)Mr. Bryan J. McEntire, Chief Technology Officer (Age 66)Mr. David O'brien, GM & VP Operations How do I buy shares of Amedica? Shares of AMDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. How big of a company is Amedica? Amedica has a market capitalization of $3.44 million and generates $11.23 million in revenue each year. The medical equipment provider earns $-9,320,000.00 in net income (profit) each year or ($3.13) on an earnings per share basis. Amedica employs 33 workers across the globe. What is Amedica's official website? The official website for Amedica is http://www.amedica.com. How can I contact Amedica? Amedica's mailing address is 1885 WEST 2100 SOUTH, SALT LAKE CITY UT, 84119. The medical equipment provider can be reached via phone at 801-839-3500 or via email at [email protected] MarketBeat Community Rating for Amedica (NASDAQ AMDA)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 243 (Vote Outperform)Underperform Votes: 234 (Vote Underperform)Total Votes: 477MarketBeat's community ratings are surveys of what our community members think about Amedica and other stocks. Vote "Outperform" if you believe AMDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMDA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/17/2019 by MarketBeat.com StaffFeatured Article: What does RSI mean?